Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors (2018)
Fonte: Bioorganic Chemistry. Unidade: IQSC
Assuntos: MOLÉCULA, QUÍMICA MÉDICA
ABNT
CIANNI, Lorenzo et al. Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors. Bioorganic Chemistry, p. 285-292, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.bioorg.2018.04.006. Acesso em: 22 ago. 2024.APA
Cianni, L., Satori, G. R., Rosini, F., De Vitta, D., Pires, G. L. de P., Lopes, B. R., et al. (2018). Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors. Bioorganic Chemistry, 285-292. doi:10.1016/j.bioorg.2018.04.006NLM
Cianni L, Satori GR, Rosini F, De Vitta D, Pires GL de P, Lopes BR, Leitão A, Burtoloso ACB, Montanari CA. Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors [Internet]. Bioorganic Chemistry. 2018 ; 285-292.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.bioorg.2018.04.006Vancouver
Cianni L, Satori GR, Rosini F, De Vitta D, Pires GL de P, Lopes BR, Leitão A, Burtoloso ACB, Montanari CA. Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors [Internet]. Bioorganic Chemistry. 2018 ; 285-292.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.bioorg.2018.04.006